Beyond the Solution
The Latest News from the New Frontier of Pharma
Windgap Medical Welcomes Mike Ratigan as Business Development Advisor
WATERTOWN, Mass., June 25, 2026 — Windgap Medical, Inc., a drug-device combination product company developing dual-cartridge autoinjector platforms for complex injectable drugs, is pleased to announce that Mike Ratigan has joined the company as a Business Development Advisor.
Windgap Medical Expands Capacity with Investment in Next-Generation Testing Infrastructure
Windgap Medical announced a significant expansion of its testing capabilities through investment in next-generation infrastructure. The new equipment enhances Windgap’s ability to conduct rigorous performance and reliability testing for its autoinjector platforms, supporting accelerated timelines for drug-device combination product development across its customer programs.
Windgap Medical Advances to Next Phase with Leading Pharmaceutical Partner for Its OneMix Platform
Windgap Medical announced advancement to the next phase of development with a leading pharmaceutical partner using its OneMix platform, a single-use autoinjector designed for mixing and delivering combination drug products. The milestone reflects continued progress in translating Windgap’s proprietary delivery technologies into viable commercial drug-device combinations.
Windgap Medical Announces Multi-Program Collaboration with Top 5 Global Pharmaceutical Company
Windgap Medical announced a strategic multi-program collaboration with a top 5 global pharmaceutical company to advance drug-device combination products using Windgap’s proprietary autoinjector platforms. The partnership encompasses multiple programs and underscores the growing demand for Windgap’s innovative delivery technologies in complex drug formulations.
Beyond the Barrel: A Dual-Cartridge Improvement to Traditional Dual-Chamber Devices
Dr. Brent Buchine explores how Windgap Medical’s parallel dual-cartridge architecture delivers significant advantages over traditional dual-chamber cartridge configurations for the mixing and delivery of combination drug products.
Injecting Sustainability: The 4th “R”—Responsibility
How Windgap is reducing environmental impact through innovation, partnerships, and a proactive approach.
Reducing Energy: Eliminating The Cold Chain
How Windgap Medical’s lyophilized autoinjector platforms cut CO2 Emissions and Costs
Reducing Operational Waste: Streamlining Drug Development with Innovative Autoinjectors
Discover how automating, accelerating, and simplifying complex drug delivery can save time, resources, energy—and the planet.
Injecting Sustainability: Maximizing Complex Formulations to Minimize Carbon Footprints
Find out how lyophilization, long-acting injectables, and sequential delivery can substantially reduce waste and environmental impact.
Challenging the “3R” Rhetoric in the Autoinjector Industry
Pharmaceutical companies that want to ‘move the needle’ on sustainability efforts can take a more proactive approach to reduce their footprints. Here’s why.
Designing for Success: Choosing the Right Primary Drug Container for Prefilled Delivery Devices
Brent Buchine and Jason Durkin of Windgap Medical examine how the choice of primary drug container—prefilled syringe, dual-chamber syringe, or cartridge—shapes device design, fill-finish manufacturability, drug stability, and regulatory strategy for prefilled delivery devices.
Windgap Medical Profiled on ‘Drug Development & Delivery’ Website
Windgap Medical offers drug delivery devices that simplify, auto-mate, and accelerate the administration of complex injectables.
In The Thick Of It: Accelerating The Mixing And Delivery Of High-viscosity Injectables
Brent Buchine, Miriam Silton, Jameson Woods and Andrew Ryan explore how the combination of gas power and a side-by-side cartridge configuration increases the working viscosity range for the mixing and delivery of complex injectable formulations.
Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy
Windgap Medical Appoints Max Meehan as Director of Corporate Development and Strategy
Windgap Medical Appoints Jason Durkin as Vice President, SupplyChain
The autoinjector platform company known for its wet-dry drug delivery technology expands the leadership team.
Windgap Medical Appoints Anthony (“Tony”) Watson as Vice President, Regulatory Affairs and Quality
The autoinjector platform company known for its wet-dry drug delivery technology expands the leadership team.
Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO
The autoinjector platform company known for its wet-dry drug delivery technology deepens its leadership bench.
Patient-centric Design Can Be a Faster Path to Market
Brent Buchine considers a faster path to market for automated and easy-to-use reconstitution devices through simplification of the delivery systems.
It’s Time to Level Up Lyo – Introducing a Swift Shift in Dual-chamber Autoinjector Technology
Co-Founder Brent Buchine discusses the need for automated, easy-to-use reconstitution devices, especially in lyophilised medications, and introduces Windgap Medical’s technology platforms, which rise to the challenge.
Windgap Medical, Inc. Closes Over $39 Million of Series B-1 Investment, More Than Twenty Percent Over Its Initial Goal
Windgap Medical, Inc., a leading specialty pharmaceutical and drug delivery platform company, announced today that it has successfully completed its final close with over $39 million of Series B-1 equity financing, led by Taiwania Capital.